79 results
8-K
EX-99.1
9hb8zit
14 Nov 23
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update
4:05pm
8-K
EX-99.1
oqllhed5k5z
3 Nov 23
Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection
4:05pm
8-K
EX-99.1
b2dlkbz yf3qzha1
2 Oct 23
Other Events
4:41pm
8-K
EX-99.1
xuitvn
14 Aug 23
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update
7:10am
UPLOAD
vyn1 0re73g3k1k186
5 Jul 23
Letter from SEC
12:00am
8-K
EX-1.1
2o15l
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm